This is an old revision of this page, as edited by Mcfer2k (talk | contribs) at 20:16, 6 August 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:16, 6 August 2011 by Mcfer2k (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | Al2Mg6(OH)14(CO3)2 · 4 H2O |
Molar mass | 314.99 g/mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.
Adverse effects
Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.
References
- Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6548918, please use {{cite journal}} with
|pmid=6548918
instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6439224, please use {{cite journal}} with
|pmid=6439224
instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6548926, please use {{cite journal}} with
|pmid=6548926
instead.
Drugs for acid related disorders: Antacids (A02A) | |
---|---|
Magnesium (increases motility) | |
Aluminium (decreases motility) | |
Calcium | |
Sodium | |
Combinations and complexes of aluminium, calcium and magnesium |
This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |